Gyre Therapeutics, Inc. SEC filings GYRE
Gyre Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Sep 10, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | May 2, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 4, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 20, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | Apr 29, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 8, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 19, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 8, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 9, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | Aug 17, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 16, 2015 | Dec 31, 2014 |
| ARS | Annual report to shareholders | Apr 24, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 14, 2014 | Dec 31, 2013 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GYRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1124105
- Former names
- CATALYST BIOSCIENCES, INC. (until Oct 27, 2023); TARGACEPT INC (until Aug 19, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.